ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Piramal will expand Canadian API plant

by Michael McCoy
February 1, 2020 | APPEARED IN VOLUME 98, ISSUE 5

 

Piramal Enterprises’ pharma solutions business will spend close to $20 million to add an active pharmaceutical ingredient (API) synthesis wing to its facility in Aurora, Ontario. At about 1,000 m2, the new wing will include two reactor suites, a dedicated filter-dryer room, and a portable filter dryer, the company says. It will allow the facility to provide APIs down to an occupational exposure limit of 1 µg/m3, the firm adds.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment